生物活性成分研发商Debut筹集2000万美元融资，加速皮肤长寿领域的人工智能成分发现，并在美国和亚洲拓展其配方业务-动脉网

Debut Raises $20M to Fast-track AI Ingredient Discovery in Skin Longevity and Grow its Formulation Business in the US and Asia

CISION 等信源发布 2025-08-26 20:59



可切换为仅中文







SAN DIEGO

圣地亚哥

，

Aug. 26, 2025

2025年8月26日

/PRNewswire/ --

Debut

首次登场

, the biotech beauty leader, has secured

，生物技术美容领域的领导者，已经确保了

$20M

2000万美元

in investment to accelerate the expansion of its proprietary, AI-based ingredient discovery platform to advance skin longevity innovation and scale its formulation business in the US and

在投资方面，加速扩展其基于人工智能的专有成分发现平台，推动皮肤长寿创新，并扩大其在美国的配方业务。

Asia

亚洲

。

继续阅读

Image credit: Mark Wall, Debut

图片来源：马克·沃尔，首次亮相

The funding will propel the discovery of next-generation ingredients that target the 14 hallmarks of aging and empower Debut's global beauty partners to innovate with peak-performing biotech ingredients and formulations married to novel claims. It will also enable beauty brands at all stages of growth to outsource their formulation innovation in record time, at scale and without the heavy upfront R&D expense associated with biotech..

这笔资金将推动发现针对衰老14个标志的下一代成分，并助力Debut的全球美容合作伙伴利用高效生物技术成分和配方创新，结合新颖宣称。它还将使各成长阶段的美容品牌能够以创纪录的时间外包其配方创新，实现规模化，且无需承担与生物技术相关的高额前期研发费用。

'Debut is laser-focused on staying at the forefront of skincare innovation and bringing cutting-edge biotech to every beauty brand with the highest-performing and most differentiated ingredients. This funding will enhance our ability to screen upward of 50 billion ingredients to explore the 99.999 percent of unknown molecules that can optimize skin health and make skin longevity a reality,' said .

“Debut 致力于站在护肤品创新的前沿，将尖端生物技术带给每个美容品牌，提供最高性能和最具差异化的成分。这笔资金将增强我们筛选超过 500 亿种成分的能力，探索能够优化皮肤健康的 99.999% 的未知分子，让皮肤长寿成为现实，”该公司表示。

Joshua Britton

约书亚·布里顿

, PhD, Founder and CEO of Debut.

博士，Debut创始人兼首席执行官。

The predictive capabilities of Debut's proprietary, in-house skin health datasets recently surpassed publicly available datasets, achieving 99 percent data consistency compared to 85 percent in public datasets. 'This means we can predict better ingredients, faster, with our best-in-class models that we have invested in over several years.

Debut的专有内部皮肤健康数据集的预测能力最近超过了公开可用的数据集，达到了99%的数据一致性，而公共数据集的一致性为85%。 “这意味着我们可以使用我们多年来投入的最佳模型更快、更好地预测成分。

We are excited to go after novel chemical entities (NCEs), as opposed to chasing existing ingredients in nature, to pioneer skin health innovation and support the growth of beauty brands,' said Britton..

布里顿表示：“我们很高兴能够追求新型化学实体（NCEs），而不是追逐自然界中已有的成分，以此开创皮肤健康创新并支持美容品牌的成长。”

Debut's funding raise comes at a time marked by increased investor caution. The company is poised to enter the Asian market which is driven by advanced formulations and high-performance skincare. 'AI combined with an understanding of skin biology enables the creation of custom formulation solutions for different geographies that has previously not been possible,' said Britton.

Debut此次融资正值投资者更加谨慎的时期。该公司准备进入由先进配方和高效护肤推动的亚洲市场。Britton表示：“人工智能结合对皮肤生物学的理解，能够为不同地区创建以前无法实现的定制配方解决方案。”

Debut's expansion into .

Debut扩展到。

Asia

亚洲

will begin in

将在以下时间开始：

Singapore

新加坡

where the company will be partnering with leading brands to create custom ingredients and formulations for longevity skincare.

公司将与领先品牌合作，为长寿护肤创造定制成分和配方。

The most recent fundraising round was supported by Fine Structure Ventures, EDBI, Wealthberry, BOLD (the venture fund of L'Oréal), GS Futures, Sandbox Industries and Material Impact, among others.

最近一轮融资得到了 Fine Structure Ventures、EDBI、Wealthberry、BOLD（欧莱雅的风险基金）、GS Futures、Sandbox Industries 和 Material Impact 等的支持。

Debut

首秀

The leader in biotech beauty

生物科技美容的领导者

Debut is building the future of beauty with cutting-edge AI and biotechnology, creating high-performing, innovative ingredients and formulations that propel the industry forward. The company specializes in scientifically-discovered, clinically-proven and inherently sustainable ingredients that provide maximum efficacy.

Debut正利用尖端的人工智能和生物技术构建美容行业的未来，创造高性能、创新的成分和配方，推动行业向前发展。该公司专注于科学发现、临床验证且本质上可持续的成分，提供最大的功效。

Named one of the .

被评为其中之一。

TIME100

时代100

Most Innovative Companies 2025, Debut is redefining the beauty industry's standards, centering on performance, potency and purity.

2025年最具创新力公司榜单中，Debut正在重新定义美容行业的标准，聚焦于功效、强度和纯度。

SOURCE Debut Biotechnology

源初生物科技

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻吗？

FEATURED ON PRNEWSWIRE.COM?